Personal Capital Advisors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $396K | Buy |
3,016
+139
| +5% | +$18.2K | ﹤0.01% | 338 |
|
|
2022
Q3 | $336K | Buy |
2,877
+88
| +3% | +$10.3K | ﹤0.01% | 336 |
|
|
2022
Q2 | $328K | Sell |
2,789
-513
| -16% | -$60.3K | ﹤0.01% | 331 |
|
|
2022
Q1 | $430K | Buy |
3,302
+228
| +7% | +$29.7K | ﹤0.01% | 329 |
|
|
2021
Q4 | $469K | Sell |
3,074
-141
| -4% | -$21.5K | ﹤0.01% | 346 |
|
|
2021
Q3 | $520K | Buy |
3,215
+417
| +15% | +$67.4K | ﹤0.01% | 306 |
|
|
2021
Q2 | $458K | Buy |
2,798
+100
| +4% | +$16.4K | ﹤0.01% | 324 |
|
|
2021
Q1 | $406K | Buy |
2,698
+395
| +17% | +$59.4K | ﹤0.01% | 335 |
|
|
2020
Q4 | $349K | Buy |
2,303
+359
| +18% | +$54.4K | ﹤0.01% | 350 |
|
|
2020
Q3 | $263K | Buy |
1,944
+83
| +4% | +$11.2K | ﹤0.01% | 358 |
|
|
2020
Q2 | $254K | Buy |
+1,861
| New | +$254K | ﹤0.01% | 315 |
|